Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (431-440 of 706) with videos related to

Pageof 71
Sort By:
Metabolism: Clinical and Experimental|February 26, 2003
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight menAnthony P James, Gerald F Watts, P Hugh R Barrett, et al.
Atherosclerosis|October 2, 2018
Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of familiesThanh Huong Truong, Ngoc Thanh Kim, Mai Ngoc Thi Nguyen, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary DiseasePrasanna Venkataraman, Hiroshi Kawakami, Quan Huynh, et al.
Scientific Reports|December 16, 2018
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Matteo Pirro, et al.
Journal of Clinical Lipidology|August 12, 2014
Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemiaZanfina Ademi, Gerald F Watts, Jing Pang, et al.
Heart, Lung & Circulation|December 6, 2025
Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?Ralph G Audehm, Danny Liew, Gerald F Watts, et al.
Journal of Clinical Lipidology|July 29, 2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patientsLeopoldo Pérez de Isla, Rodrigo Alonso, Rosa Argüeso, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin TreatmentTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol effluxDick C Chan, Anh Hoang, P Hugh R Barrett, et al.
European Journal of Clinical Investigation|November 18, 2018
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery diseaseLouis Ma, Elisa Waldmann, Esther M M Ooi, et al.
Pageof 71

Showing results (431-440 of 706) with videos related to

Sort By:
Pageof 71
Metabolism: Clinical and Experimental|February 26, 2003
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight menAnthony P James, Gerald F Watts, P Hugh R Barrett, et al.
Atherosclerosis|October 2, 2018
Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of familiesThanh Huong Truong, Ngoc Thanh Kim, Mai Ngoc Thi Nguyen, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary DiseasePrasanna Venkataraman, Hiroshi Kawakami, Quan Huynh, et al.
Scientific Reports|December 16, 2018
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Matteo Pirro, et al.
Journal of Clinical Lipidology|August 12, 2014
Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemiaZanfina Ademi, Gerald F Watts, Jing Pang, et al.
Heart, Lung & Circulation|December 6, 2025
Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?Ralph G Audehm, Danny Liew, Gerald F Watts, et al.
Journal of Clinical Lipidology|July 29, 2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patientsLeopoldo Pérez de Isla, Rodrigo Alonso, Rosa Argüeso, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin TreatmentTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol effluxDick C Chan, Anh Hoang, P Hugh R Barrett, et al.
European Journal of Clinical Investigation|November 18, 2018
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery diseaseLouis Ma, Elisa Waldmann, Esther M M Ooi, et al.
Pageof 71